BioLineRx
BLRX----
全部股東
股東類型
- 公眾及其他94.89%
- 上市公司3.43%
- 機構投資者1.34%
- 個人與內幕人士0.34%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Lepu Medical Technology (Beijing) Co., Ltd. | 3.43% | 1.02 億 | 0.49% | +0 | 16/03/2025 |
Susquehanna International Group, LLP | 0.62% | 1,854.66 萬 | -- | +1,854.66 萬 | 30/06/2026 |
Renaissance Technologies LLC | 0.31% | 924.72 萬 | -- | +924.72 萬 | 30/06/2026 |
Citadel Advisors LLC | 0.30% | 887.76 萬 | 0.30% | +887.76 萬 | 30/06/2026 |
Philip SerlinChief Executive Officer | 0.17% | 513.18 萬 | 0.02% | +0 | 18/03/2026 |
Aharon SchwartzIndependent Chairman of the Board | 0.12% | 370.50 萬 | 0.02% | +0 | 18/03/2026 |
Rhumbline Advisers Ltd Partnership | 0.05% | 148.68 萬 | <0.01% | +7.50 萬 | 30/06/2026 |
Mali ZeeviChief Financial Officer | 0.04% | 131.10 萬 | <0.01% | +0 | 18/03/2026 |
Wells Fargo & Company | 0.04% | 120.00 萬 | <0.01% | +15.00 萬 | 30/06/2026 |
BNP Paribas Financial Markets SNC | 0.01% | 30.00 萬 | 0.03% | -78.00 萬 | 30/06/2026 |
Nemes Rush Group, LLC | <0.01% | 15.00 萬 | <0.01% | +0 | 30/06/2026 |
Ella SoraniChief Development Officer | <0.01% | 6.66 萬 | <0.01% | +0 | 16/03/2025 |
UBS Asset Management AG | <0.01% | 6.06 萬 | 0.01% | -25.68 萬 | 30/06/2026 |
NewEdge Advisors, LLC | <0.01% | 4.92 萬 | <0.01% | -1.50 萬 | 30/06/2026 |
Osaic Wealth, Inc. | <0.01% | 1.56 萬 | <0.01% | +0 | 30/06/2026 |
SBI Holdings, Inc. | <0.01% | 6,000.00 | <0.01% | +0 | 30/09/2026 |
Danske Capital AS (Estonia) | <0.01% | 1,200.00 | <0.01% | +0 | 30/06/2026 |
Citigroup Inc. | <0.01% | 600.00 | 0.04% | -103.62 萬 | 30/06/2026 |
Rockefeller & Co. LLC | 0.00% | 0.00 | <0.01% | -7,200.00 | 30/06/2026 |
XTX Markets Limited | 0.00% | 0.00 | 0.25% | -656.46 萬 | 30/06/2026 |